Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Brain-derived neurotrophic factor in Huntington disease.
Ferrer I, Goutan E, Marín C, Rey MJ, Ribalta T. Ferrer I, et al. Brain Res. 2000 Jun 2;866(1-2):257-61. doi: 10.1016/s0006-8993(00)02237-x. Brain Res. 2000. PMID: 10825501
Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
Muntané G, Dalfó E, Martínez A, Rey MJ, Avila J, Pérez M, Portero M, Pamplona R, Ayala V, Ferrer I. Muntané G, et al. J Neurochem. 2006 Oct;99(1):177-85. doi: 10.1111/j.1471-4159.2006.04032.x. J Neurochem. 2006. PMID: 16987245
Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T. Ferrer I, et al. Brain Pathol. 2001 Apr;11(2):144-58. doi: 10.1111/j.1750-3639.2001.tb00387.x. Brain Pathol. 2001. PMID: 11303790
Prion protein expression in senile plaques in Alzheimer's disease.
Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T. Ferrer I, et al. Acta Neuropathol. 2001 Jan;101(1):49-56. doi: 10.1007/s004010000271. Acta Neuropathol. 2001. PMID: 11194941
BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.
Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Martí E. Ferrer I, et al. J Neuropathol Exp Neurol. 1999 Jul;58(7):729-39. doi: 10.1097/00005072-199907000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10411343
Brain-derived neurotrophic factor in patients with frontotemporal dementia.
Ferrer I, Marín C, Rey MJ, Ribalta T. Ferrer I, et al. Neurosci Lett. 2000 Jan 21;279(1):33-6. doi: 10.1016/s0304-3940(99)00937-4. Neurosci Lett. 2000. PMID: 10670781
Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation.
Ferrer I, Pastor P, Rey MJ, Muñoz E, Puig B, Pastor E, Oliva R, Tolosa E. Ferrer I, et al. Neuropathol Appl Neurobiol. 2003 Feb;29(1):23-34. doi: 10.1046/j.1365-2990.2003.00435.x. Neuropathol Appl Neurobiol. 2003. PMID: 12581337
Clinical and neuropathological variability in clinically isolated central nervous system Whipple's disease.
Balasa M, Gelpi E, Rey MJ, Vila J, Ramió-Torrentà L, Quiles Granado AM, Molina Latorre R, Lepidi H, Raoult D, Saiz A. Balasa M, et al. Among authors: rey mj. Brain Pathol. 2014 Apr;24(3):230-8. doi: 10.1111/bpa.12113. Epub 2014 Jan 13. Brain Pathol. 2014. PMID: 24320005
Familial Alzheimer disease associated with A713T mutation in APP.
Armstrong J, Boada M, Rey MJ, Vidal N, Ferrer I. Armstrong J, et al. Neurosci Lett. 2004 Nov 11;370(2-3):241-3. doi: 10.1016/j.neulet.2004.08.026. Neurosci Lett. 2004. PMID: 15488330
99 results
Jump to page
Feedback